ISTH 2021 Congress

July 17-21, 2021. Philadelphia, PA.

• Arterial Thromboembolism (69)
  • Acute Coronary Syndromes (10)
  • Atherosclerosis (19)
  • Cardiovascular Risk Factors (14)
  • Cerebrovascular Disorders (20)
  • Peripheral Artery Disease (6)
• Coagulation and Natural Anticoagulants (158)
  • Animal Models in Thrombosis and Hemostasis (14)
  • Coagulation Factors and Inhibitors (53)
  • Contact Pathway (11)
  • Critical Care and Perioperative (25)
  • FVIII/IX (8)
  • Hemostasis and Organ Dysfunction (9)
  • Microparticles (4)
  • Protein C Pathway (6)
  • Regulation of Coagulation (22)
  • Tissue Factor Pathway (6)
• COVID and Coagulation (210)
  • COVID and Coagulation, Basic Science (44)
  • COVID and Coagulation, Clinical (166)
• Diagnostics and OMICs (113)
  • Biomarkers of Thrombosis and Hemostasis (14)
  • Blood Components and Management (5)
  • Cellular Therapies (2)
  • Epigenetics, OMICs and Bioinformatics (5)
  • Laboratory Diagnostics (83)
  • Nanotechnology and Novel Biomolecules (4)
• Fibrinogen, Fibrinolysis and Proteolysis (53)
  • Fibrinogen and Factor XIII (24)
  • Fibrinolytic Factors and Inhibitors (19)
  • Plasminogen Activation in the CNS and Immunity (3)
  • Thrombolytic Therapy (7)
• Hemophilia and Rare Bleeding Disorders (365)
  • Acquired Hemorrhagic Coagulation Disorders (21)
  • Disseminated Intravascular Coagulation (1)
  • Hemophilia - Basic (53)
  • Hemophilia - Clinical (175)
  • Hemophilia Gene Therapy (30)
  • Management of Bleeding and Trauma (15)
  • Novel Biotherapeutics in Hemophilia (23)
  • Rare Bleeding Disorders (47)
• Nurses (11)
  • Nurses and Allied Health (11)
• Pediatrics (62)
  • Bleeding in Neonates and Children (13)
  • Thrombosis in Neonates and Children (49)
• Platelet Disorders, von Willebrand Disease and Thrombotic Microangiopathies (181)
  • Acquired Thrombocytopenias (26)
  • ADAMTS13 and TTP (25)
  • Antiplatelet Therapy (3)
  • HIT (12)
  • HUS (1)
  • Inherited Thrombocytopenias (14)
  • Non HUS/TTP Microangiopathies (3)
  • Platelet Antagonists and Novel Therapeutics (6)
  • Platelet Function Disorders, Acquired (10)
  • Platelet Function Disorders, Hereditary (21)
  • von Willebrand Factor Biology (14)
  • VWF and von Willebrand Factor Disorders - Clinical Conditions (46)
• Platelets and Megakaryocytes (115)
  • Megakaryocytes and Thrombopoiesis (12)
  • Platelet Function and Interactions (67)
  • Platelet Proteomics and Genomics (5)
  • Platelet Receptors (13)
  • Platelet Signaling (18)
• Role of Hemostatic System in Cancer, Inflammation and Immunity (67)
  • Coagulation Proteins Beyond Hemostasis (21)
  • Complement and Hemostatic System (6)
  • Infection and Hemostatic Factors (4)
  • Platelets and Cancer (20)
  • Platelets and Infection (9)
  • Platelets and Inflammation (3)
  • Proteases and Cancer (4)
• Vascular Biology (33)
  • Blood Cells and Vessel Wall (17)
  • Endothelial Cell Signaling (1)
  • Inflammation and Sepsis (5)
  • Innate and Adaptive Immunity (3)
  • Non-coding RNAs (3)
  • Protease Activated Receptors (2)
  • Stem Cells and Vascular Cell Growth (2)
• Venous Thromboembolism (320)
  • Antiphospholipid Syndrome (25)
  • Atrial Fibrillation (19)
  • Cancer Associated Thrombosis (75)
  • Genetic Risk Factors of Thrombosis (12)
  • Post-thrombotic Syndrome (6)
  • Thrombophilia (26)
  • Visceral Vein Thrombosis (4)
  • VTE Diagnosis (21)
  • VTE Epidemiology (39)
  • VTE Prophylaxis (25)
  • VTE Treatment (68)
• Women Health (52)
  • Estrogens and Progestinics (12)
  • Pregnancy and Pregnancy Complications (41)